INVENTIVA (EPA:IVA) | Finanzwire

Basculer en Français

10105	Companies
207054	Keywords
137205	Articles
109742	Press releases

Home
Companies
INVENTIVA

PRESS RELEASE

published on 01/24/2025 at 22:00, 1 year 2 months ago

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
Inventiva announces half-year liquidity contract review with Kepler Cheuvreux. Cash and shares available in the liquidity account disclosed. Company focuses on developing oral small molecule therapies for MASH and unmet medical needs

Liquidity Contract Kepler Cheuvreux Clinical-Stage Biopharmaceutical Inventiva MASH
BRIEF

published on 01/22/2025 at 22:05, 1 year 2 months ago

Inventiva's LEGEND Trial Results to be Presented at EASL SLD Summit 2025

Lanifibranor Empagliflozin LEGEND Trial MASH Treatment EASL Summit 2025
PRESS RELEASE

published on 01/22/2025 at 22:00, 1 year 2 months ago

Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025
Inventiva announces selection of LEGEND trial results evaluating lanifibranor and empagliflozin for oral presentation at EASL SLD Summit 2025, showing positive outcomes in MASH patients with T2D

Inventiva MASH Lanifibranor Empagliflozin LEGEND Trial
BRIEF

published on 12/17/2024 at 22:05, 1 year 3 months ago

Inventiva to present at the JP Morgan Healthcare Conference

Investors Inventiva NASH Lanifibranor JP Morgan Healthcare
PRESS RELEASE

published on 12/17/2024 at 22:00, 1 year 3 months ago

Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference
Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference with CEO Frédéric Cren providing a corporate overview and engaging in investor meetings

Biopharmaceutical Inventiva J.P. Morgan Healthcare Conference Frédéric Cren Metabolic Dysfunction
BRIEF

published on 12/12/2024 at 22:05, 1 year 3 months ago

Inventiva Announces Shareholders’ Meeting Vote Results

Voting Results Shareholders' Meeting Biopharmaceutical Resolutions Inventiva
PRESS RELEASE

published on 12/12/2024 at 22:00, 1 year 3 months ago

Results of the votes of the Combined Shareholders’ General Meeting of December 11, 2024
Inventiva announces voting results of Combined Shareholders' General Meeting on December 11, 2024. All resolutions were adopted except the 59th resolution

Voting Results Shareholders' Meeting Clinical-Stage Biopharmaceutical Inventiva NASH
BRIEF

published on 11/21/2024 at 22:05, 1 year 4 months ago

Inventiva's Financial Overview for Q3 2024

Financial Results Cash Position Equity Raise Royalty Certificates R&D Expenses
PRESS RELEASE

published on 11/21/2024 at 22:00, 1 year 4 months ago

Inventiva reports 2024 Third Quarter Financial Information¹
Inventiva reports strong financial position with €13.9 million cash at September 30, 2024. R&D expenses down 10% in 2024. Key milestones and future conference participation announced

Financial Information Cash Position Inventiva R&D Expenses Key Milestones
BRIEF

published on 11/20/2024 at 22:05, 1 year 4 months ago

Inventiva Combined General Meeting: Documents Available

Funding Documents General Assembly Inventiva NASH

Accesswire

Published on 03/27/2026 at 15:35, 2 hours 16 minutes ago

SouthGobi Announces Fourth Quarter and Full Year 2025 Financial and Operating Results
Published on 03/27/2026 at 12:30, 5 hours 21 minutes ago

Pasinex Closes First Tranche of Over-Subscribed Non-Brokered Private Placement
Published on 03/27/2026 at 12:00, 5 hours 51 minutes ago

Temas Appoints Scientific Advisory Board to Accelerate RCL Commercialisation and Global Development
Published on 03/27/2026 at 12:00, 5 hours 51 minutes ago

Athena Gold Announces Share Consolidation
Published on 03/27/2026 at 11:00, 6 hours 51 minutes ago

RE Royalties Announces Strategic Review to Evaluate Path for Long-Term Value Creation

View all ACCESSWIRE

EQS Group

Published on 03/27/2026 at 17:45, 6 minutes ago

DKSH’s 93rd Annual General Meeting 2026
Published on 03/27/2026 at 17:45, 6 minutes ago

ENOGIA: 2025 annual results
Published on 03/27/2026 at 17:30, 21 minutes ago

Holding(s) in Company
Published on 03/27/2026 at 15:58, 1 hour 53 minutes ago

coinIX remains resilient in volatile market environment with balanced annual result | CEO Moritz Schildt sees entry-level prices in the crypto market
Published on 03/27/2026 at 15:50, 2 hours 1 minute ago

EQS-Adhoc: Klöckner & Co SE: Worthington Steel announces intention to enter into a domination and profit and loss transfer agreement with Klöckner & Co SE

Les Echos

Published on 03/27/2026 at 17:45, 6 minutes ago

PUBLICATION OF THE UNIVERSAL REGISTRATION DOCUMENT FISCAL YEAR 2025
Published on 03/27/2026 at 17:45, 6 minutes ago

Availability of the 2025 Universal Registration Document including the Annual Financial Report
Published on 03/27/2026 at 17:45, 6 minutes ago

ORDINARY GENERAL MEETING OF 5 MAY 2026 AVAILABILITY OF THE PREPARATORY DOCUMENTS
Published on 03/27/2026 at 17:45, 6 minutes ago

COMBINED GENERAL MEETING OF 5 MAY 2026 AVAILABILITY OF THE PREPARATORY DOCUMENTS
Published on 03/27/2026 at 17:40, 11 minutes ago

Creation of a General Operations Department

View all LES ECHOS COMFI WIRE